David Beasley, PhD

David W.C. Beasley, PhD
Professor
Department of Microbiology & Immunology

Director, Regulatory & Scientific Affairs, Institutional Office of Regulated Non-clinical Studies

Associate Director, World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases

Phone: (409) 772-1120
Mail Route: 0609
Office: Keiller Building 2.138F
Email: dwbeasle@utmb.edu

Education
PhD, Life Sciences Queensland University of Technology (QUT)	1999 Brisbane, Australia
BASc (Hons), Life Sciences Queensland University of Technology (QUT)	1993 Brisbane, Australia
BASc, Medical Laboratory Science Queensland University of Technology (QUT)	1992 Brisbane, Australia

Research Interests
Molecular basis of virulence and antigenic variations between West Nile virus (WNV) strains, arbovirus vaccines and diagnostics, Good Laboratory Practices (GLP), animal models for infectious diseases

Current Research
Dr. Beasley's research focuses on the molecular basis of virulence and antigenic variations between strains of West Nile virus and other flaviviruses. His lab's wider research activities include studies related to the development of improved diagnostic and therapeutic reagents and vaccines for flaviviruses and other arboviruses. Dr. Beasley is the Director of Regulatory and Scientific Affairs for the Institutional Office of Regulated Nonclinical Studies where he oversees the implementation and operation of GLP-based quality systems to facilitate conduct of animal model development and efficacy studies at ABSL3/ABSL4 necessary to support future licensure of medical countermeasures for biodefense and emerging disease agents under the FDA’s Animal Rule.

Current Research

Dr. Beasley's research focuses on the molecular basis of virulence and antigenic variations between strains of West Nile virus and other flaviviruses. His lab's wider research activities include studies related to the development of improved diagnostic and therapeutic reagents and vaccines for flaviviruses and other arboviruses. Dr. Beasley is the Director of Regulatory and Scientific Affairs for the Institutional Office of Regulated Nonclinical Studies where he oversees the implementation and operation of GLP-based quality systems to facilitate conduct of animal model development and efficacy studies at ABSL3/ABSL4 necessary to support future licensure of medical countermeasures for biodefense and emerging disease agents under the FDA’s Animal Rule.

Publications
Search PubMed Database for Publications